Adaptive Biotechnologies Corp. Stock, NASDAQ:ADPT
1551 Eastlake Avenue East, Suite 200, Seattle, Washington 98102
United States of America
Number of Employees: 453
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.